Cariprazine Trumps Risperidone for Negative Schizophrenia Symptoms Cariprazine Trumps Risperidone for Negative Schizophrenia Symptoms
Cariprazine is more effective than risperidone for persistent negative symptoms in schizophrenia and appears to be effective in patients resistant to previous treatment with other antipsychotic agents.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 9, 2020 Category: Consumer Health News Tags: Psychiatry News Source Type: news

How to manage patients on long-acting injectable (LAI, or depot) antipsychotics during the COVID-19 pandemic, NIHR
This guidance includes information about LAI antipsychotic medications which are currently licensed in the UK (that is: Xeplion ® , Trevicta ® , Abilify Maintena ® , Risperdal Consta ® , Zypadhera ® ) (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

First-in-Class Antipsychotic Linked to Lower Cardiometabolic Risk First-in-Class Antipsychotic Linked to Lower Cardiometabolic Risk
A recently approved first-in-class antipsychotic appears to have fewer adverse cardiometabolic effects compared with placebo or standard care with risperidone, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 3, 2020 Category: Neurology Tags: Psychiatry News Source Type: news

CHMP Backs Generic Paliperidone for Schizophrenia CHMP Backs Generic Paliperidone for Schizophrenia
Paliperidone Janssen-Cilag International, a generic of Xeplion, is for maintenance treatment of schizophrenia in adults stabilized with paliperidone or risperidone and select other cases.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 2, 2020 Category: Consumer Health News Tags: Psychiatry News Source Type: news

How Aripiprazole's Promise for Treating Autism Fell Short
Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade's worth of data suggests that is not true. (Source: The Scientist)
Source: The Scientist - February 27, 2020 Category: Science Tags: News & Opinion Source Type: news

Perseris (Risperidone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 18, 2020 Category: Drugs & Pharmacology Source Type: news

Stepped treatment for attention-deficit/hyperactivity disorder and aggressive behavior: a randomized, controlled trial of adjunctive risperidone, divalproex sodium, or placebo after stimulant medication optimization - Blader JC, Pliszka SR, Kafantaris V, Foley CA, Carlson GA, Crowell JA, Bailey BY, Sauder C, Daviss WB, Sinha C, Matthews TL, Margulies DM.
OBJECTIVE: Stimulant medications are the most prevalent first-line pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD), but children with aggressive behavior often receive multi-agent treatment. There is sparse evidence for the benefits of ... (Source: SafetyLit)
Source: SafetyLit - February 4, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Risperidone for psychosis-induced aggression or agitation - Scruth E.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - August 8, 2019 Category: International Medicine & Public Health Tags: Commentary Source Type: news

Delayed-onset toxicity in an adolescent case following attempted suicide with an overdose of paliperidone intake - Yaylac ı F, Küçük Ö, Erkuran HO.
Paliperidone is a relatively novel atypical antipsychotic drug that is currently used to treat schizophrenia in adolescents and adults. The drug was generated by combining the active metabolite of risperidone, 9-hydroxyrisperidone, with osmotic controlled-... (Source: SafetyLit)
Source: SafetyLit - July 18, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

DURECT Appoints Two New Board Members
CUPERTINO, Calif., April 25, 2019 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) announced today the appointment of two new members to its board of directors. Dr. Gail M. Farfel, Executive Vice President and Chief Developm... Biopharmaceuticals, Drug Delivery, Personnel DURECT, PERSERIS, risperidone, Schizophrenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 25, 2019 Category: Pharmaceuticals Source Type: news

Clozapine in the treatment of aggression in conduct disorder in children and adolescents: a randomized, double-blind, controlled trial - Ju árez-Treviño M, Esquivel AC, Isida LML, Delgado DÁG, de la O Cavazos ME, Ocañas LG, Sepúlveda RS.
This study was conducted to compare the efficacy of clozapine vs. risperidone in the treatment of aggression in conduct disorder in children and adolescents. METHODS: Twenty-four children with conduct disorder aged 6 to 16 years were ran... (Source: SafetyLit)
Source: SafetyLit - January 30, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Dopamine modulates reward experiences elicited by music
(University of Barcelona) New study in Proceedings of the National Academy of Science reveals causal link between dopamine and human reward response to music listening. Researchers pharmacologically manipulated dopaminergic transmission of 27 participants while listening to music and showed causal link between dopamine and pleasure. While levodopa increased hedonic experience and motivation, risperidone led to a reduction of both. These results shed light on neurobiology and neurochemistry underpinning reward responses, contributing to an open debate on human pleasures. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2019 Category: International Medicine & Public Health Source Type: news

Dopamine modulates the reward experiences elicited by music
(IDIBELL-Bellvitge Biomedical Research Institute) Researchers from IDIBELL-UB, the Sant Pau Hospital and the McGill University published a new study in PNAS that shows for the first time a causal link between the dopaminergic system and enjoying music. Dopamine precursor levodopa increased the musical pleasure and music-related motivational responses, such as willingness to purchase a song, while the dopamine antagonist risperidone led to a reduction of both. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2019 Category: International Medicine & Public Health Source Type: news

Commercial Launch Plans Announced for PERSERIS(TM) (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
Indivior PLC Announces Plan for Commercial Launch in February 2019 with 50 Sales Representatives CUPERTINO, Calif., Dec. 19, 2018 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) today announced that Indivior PLC (LON: IND... Biopharmaceuticals, Product Launch DURECT, PERSERIS, risperidone, Schizophrenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 19, 2018 Category: Pharmaceuticals Source Type: news

risperidone, Risperdal; Risperdal Consta, Risperdal M-TAB
Title: risperidone, Risperdal; Risperdal Consta, Risperdal M-TABCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 12/7/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 7, 2018 Category: Drugs & Pharmacology Source Type: news

Risperidone medication errors in children: an analysis of French poison centres data - Vial T, Patat AM, Paret N, Boels D, Torrents R, Nisse P, Villa A, Kassai B.
OBJECTIVES: To describe clinical consequences of risperidone medication errors in children of less than 13 years and to estimate a clinically relevant toxic dose. METHODS: All cases of risperidone medication errors managed by French Poison Centres ... (Source: SafetyLit)
Source: SafetyLit - November 21, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

'Robbed of precious time': chemical restraints and aged care | Sarah Russell
Nearly two-thirds of aged care residents are prescribed psychotropic drugs regularly. Questions that must be urgently askedThis is part of a series about aged care in AustraliaMary ’s 85-year-old husband had been in an aged care home for just over a week. He had been getting frailer but was still sharp mentally. However, Mary* became extremely worried when her husband started sleeping all day.After much ado, Mary obtained access to the medication chart for her husband. The aged care home ’s GP had prescribed risperidone (an anti-psychotic medication), oxazepan (a benzodiazepine that is highly addictive and caus...
Source: Guardian Unlimited Science - September 13, 2018 Category: Science Authors: Sarah Russell Tags: Ageing Science Society Source Type: news

Perseris (Risperidone) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 22, 2018 Category: Drugs & Pharmacology Source Type: news

FDA OKs Once-Monthly Risperidone Injection for Schizophrenia FDA OKs Once-Monthly Risperidone Injection for Schizophrenia
Clinically relevant levels of the antipsychotic are reached after the first injection without use of a loading dose or any supplemental oral risperidone.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 30, 2018 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news

FDA Approves Perseris (risperidone) for Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
SLOUGH, England and RICHMOND, Va., July 27, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that the U.S. Food and Drug Administration (FDA) has approved Perseris, the first once-monthly subcutaneous risperidone-containing, long-acting... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 27, 2018 Category: Drugs & Pharmacology Source Type: news

Aggression following traumatic brain injury: effectiveness of risperidone (AFTER): study protocol for a feasibility randomised controlled trial - Deb S, Leeson V, Aimola L, Bodani M, Li L, Weaver T, Sharp D, Crawford M.
BACKGROUND: Traumatic brain injury (TBI) is a major public health concern and many people develop long-lasting physical and neuropsychiatric consequences following a TBI. Despite the emphasis on physical rehabilitation, it is the emotional and behavioural ... (Source: SafetyLit)
Source: SafetyLit - July 2, 2018 Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news

Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Up to 75% of people with serious mental illness (SMI) such as schizophrenia and bipolar disorder have co-occurring substance use disorders (dual diagnosis). Dual diagnosis can have an adverse effect on treatment and prognosis of SMI. To evaluate the effects of risperidone compared to treatment with other antipsychotics (first-generation and other second-generation antipsychotics) used in people with serious mental illness and co-occurring substance misuse. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 25, 2018 Category: Consumer Health News Source Type: news

Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation) - Ostinelli EG, Hussein M, Ahmed U, Rehman FU, Miramontes K, Adams CE.
BACKGROUND: Aggressive, agitated or violent behaviour due to psychosis constitutes an emergency psychiatric treatment where fast-acting interventions are required. Risperidone is a widely accessible antipsychotic that can be used to manage psychosis-induce... (Source: SafetyLit)
Source: SafetyLit - April 16, 2018 Category: International Medicine & Public Health Tags: Occupational Issues Source Type: news

Risperdal (Risperidone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 12, 2018 Category: Drugs & Pharmacology Source Type: news

Lowering Antipsychotic Dose Can Improve Symptoms in Schizophrenia Lowering Antipsychotic Dose Can Improve Symptoms in Schizophrenia
Reducing the dose of risperidone and olanzapine can improve cognitive function and negative symptoms in patients with stable schizophrenia, new research from China suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 27, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Add-on Antipsychotic Promising for PTSD, Anxiety Add-on Antipsychotic Promising for PTSD, Anxiety
Patients with posttraumatic stress disorder (PTSD) who are being treated with antidepressants may experience additional symptom improvement with adjunctive risperidone, a new meta-analysis suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 5, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Comparing resource use and costs in Taiwan: LAI vs oral risperidone
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - March 1, 2018 Category: Drugs & Pharmacology Source Type: news

Clinical implications from the Treatment of Severe Childhood Aggression (TOSCA) study: a re-analysis and integration of findings - Barterian JA, Arnold LE, Brown NV, Farmer CA, Williams C, Findling RL, Kolko DJ, Bukstein OG, Molina BSG, Townsend L, Aman MG.
This article summarizes the clinical implications; reanalyzes the... (Source: SafetyLit)
Source: SafetyLit - November 30, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Risperdal Consta (Risperidone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2017 Category: Drugs & Pharmacology Source Type: news

Placebo Might Be Superior to Antipsychotics for Delirium Placebo Might Be Superior to Antipsychotics for Delirium
Is risperidone or haloperidol effective for dementia in patients receiving palliative care?Evidence-Based Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 2, 2017 Category: Consumer Health News Tags: Psychiatry Journal Article Source Type: news

Zydus Pharma recalls 44.8 K bottles of antidepressant in US
The reason for recall is presence of foreign tablets. "Risperidone tablets were found in bottle of paroxetine tablets", the report said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 21, 2017 Category: Pharmaceuticals Source Type: news

A naturalistic comparison of methylphenidate and risperidone monotherapy in drug-naive youth with attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder and aggression - Masi G, Manfredi A, Nieri G, Muratori P, Pfanner C, Milone A.
BACKGROUND/PURPOSE: Attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) are frequently co-occurring in youth, but data about the pharmacological management of this comorbidity are scarce, especially when impulsive aggres... (Source: SafetyLit)
Source: SafetyLit - August 25, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Antipsychotic Polypharmacy With Risperidone and Olanzapine Antipsychotic Polypharmacy With Risperidone and Olanzapine
Given high rates of treatment failure for initial therapy of schizophrenia, is combining risperidone and olanzapine an appropriate approach to improve clinical response and limit adverse effects?Medscape Pharmacists (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 8, 2017 Category: Consumer Health News Tags: Pharmacist Ask the Expert Source Type: news

Clinical Trial Saves Baby ’s Lungs
Treatment TermsChildren's health CategoriesClinical trialsFamily health TagsPatient story Sub-Title Baby Collier Proves He ’s a Survivor Author Burgetta Wheeler Overview Collier Hart sat smiling in his crib repeatedly saying, “Wa wa.” Given a sippy cup of water, he threw back his head and drained it. He put his hands together, fingertips touching, and made the sign for “more.” None of this is unusual for a 2-year-old, but it is for Collier. He spent the first 15 months of his life at Duke Children’s Hospital af ter being born with severely underdeveloped lungs. Hero Imageco...
Source: dukehealth.org: Health Tips - June 23, 2017 Category: Primary Care Authors: klh85 at duke.edu Source Type: news

Braeburn ’s risperidone implant meets primary endpoint in schizophrenia trial
Braeburn Pharmaceuticals said yesterday that a 6-month study of its risperidone implant in patients with schizophrenia or schizoaffective disorder met its primary endpoint. Risperidone, the most commonly-prescribed therapy for schizophrenia, depends on consistent administration, but patients with schizophrenia sometimes stop taking their medication when their symptoms improve. Long-acting, injectable formulations of risperidone are on the market, but there is no FDA-approved formulation that lasts for 6-months, according to Braeburn. Get the full story at our sister site, Drug Delivery Business News. The post Bra...
Source: Mass Device - April 27, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Implants Neurological Pharmaceuticals Wall Street Beat Braeburn Pharmaceuticals Source Type: news

Efficacy of oral risperidone, haloperidol or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial
Antispychotic drugs are widely used for distressing symptoms of delirium but efficacy has not been established in placebo-controlled trials in palliative care.The authors of this important study conclude that antipsychotics should not be added to manage specific symptoms associated with distress in palliative patients experiencing mild to moderate delirium. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 26, 2017 Category: Consumer Health News Source Type: news

Clozapine Better Than Risperidone for Curbing Cannabis Craving in Schizophrenia Clozapine Better Than Risperidone for Curbing Cannabis Craving in Schizophrenia
Clozapine appears to be superior to risperidone in reducing both subjective craving and MRI-assessed cue reactivity for cannabis-related images in male patients with schizophrenia and a cannabis use disorder (CUD), according to a new report.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 12, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Use of Antipsychotics Does Not Reduce Delirium Symptom Scores
Researchers in Australia and Canada have concluded that individualized management and supportive strategies lead to lower delirium symptom scores and a shorter duration of delirium symptoms compared with the administration of risperidone and haloperidol. (Source: Caring for the Ages)
Source: Caring for the Ages - April 1, 2017 Category: Health Management Authors: Jason Harris Source Type: news

Risperidone Orally Disintegrating Tablets, USP (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - March 28, 2017 Category: Drugs & Pharmacology Source Type: news

Risperidone versus placebo for schizophrenia
Risperidone is the first new-generation antipsychotic drug made available in the market in its generic form. To determine the clinical effects, safety and cost-effectiveness of risperidone compared with placebo for treating schizophrenia. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 28, 2017 Category: Consumer Health News Source Type: news

Antipsychotic adjunctive therapy to mood stabiliser should be continued for 6months after remission of a manic episode
One hundred and seventy-eight patients from academic centres in Canada and Brazil with bipolar I disorder and aged ≥17 years, who recently remitted from an acute manic or mixed episode with a combination of mood stabiliser (lithium or valproate) and atypical antipsychotic (risperidone or olanzapine) were randomised to one of the three following groups: (1) discontinue risperidone or olanzapine over 2 weeks beg inning on the day of randomisation and receive placebo substitution for the remaining 50 weeks; (2) receive risperidone or olanzapine for 24 weeks, followed by tapering and discontinuation of the antipsychotic ove...
Source: Current Awareness Service for Health (CASH) - March 16, 2017 Category: Consumer Health News Source Type: news

Odds of early death in Alzheimer's patients nearly doubles after taking antipsychotic drugs
(NaturalNews) Alzheimer’s patients who take antipsychotic drugs have a significantly increased risk of dying early compared to those who don’t, new research out of Finland has found. An in-depth analysis of nearly 58,000 people diagnosed with Alzheimer’s disease between 2005 and 2011 found that those who take popular antipsychotics like Abilify (aripiprazole) or Risperdeal (risperidone)... (Source: NaturalNews.com)
Source: NaturalNews.com - January 4, 2017 Category: Consumer Health News Source Type: news

Risperidone added to psychostimulant in children with severe aggression and attention-deficit/hyperactivity disorder: lack of effect on attention and short-term memory - Farmer CA, Epstein JN, Findling RL, Gadow KD, Arnold LE, Kipp H, Kolko DJ, Butter E, Schneider J, Bukstein OG, McNamara NK, Molina BS, Aman MG.
In this study, we report data from a double-blind, randomized, controlled study of stimulant plus placebo versus com... (Source: SafetyLit)
Source: SafetyLit - September 11, 2016 Category: Global & Universal Tags: Age: Adolescents Source Type: news

Withdrawing Risperidone Risky for Hallucinating Alzheimer ’s Patients
TORONTO — Hallucinations — especially auditory hallucinations — triple the risk that a risperidone-controlled Alzheimer’s patient with psychoses will relapse if the drug is withdrawn. (Source: Caring for the Ages)
Source: Caring for the Ages - August 30, 2016 Category: Health Management Authors: Michele G. Sullivan Source Type: news

Withdrawing risperidone spikes risk for psychotic relapse in hallucinating Alzheimer’s patients
TORONTO – Hallucinations – especially auditory hallucinations – triple the risk that a risperidone-controlled Alzheimer’s patient with psychoses will relapse if the drug is withdrawn. “I think the... (Source: Family Practice News)
Source: Family Practice News - July 25, 2016 Category: Primary Care Source Type: news

Withdrawing risperidone spikes risk for psychotic relapse in hallucinating Alzheimer’s patients
TORONTO – Hallucinations – especially auditory hallucinations – triple the risk that a risperidone-controlled Alzheimer’s patient with psychoses will relapse if the drug is withdrawn. “I think the... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 25, 2016 Category: Neurology Source Type: news

J&J's Janssen Hit With $70 Mln Verdict in Risperdal TrialJ&J's Janssen Hit With $70 Mln Verdict in Risperdal Trial
A U.S. jury has awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal (risperidone). Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2016 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Severely aggressive children receiving stimulant medication versus stimulant and risperidone: 12-month follow-up of the TOSCA Trial - Gadow KD, Brown NV, Arnold LE, Buchan-Page KA, Bukstein OG, Butter E, Farmer CA, Findling RL, Kolko DJ, Molina BS, Rice RR, Schneider J, Aman MG.
The objective of this study was to evaluate 52-week clinical outcomes of children with co-occurring attention-deficit/hyperactivity disorder (ADHD), disruptive behavior disorder, and serious physical aggression who participated in a prospective,... (Source: SafetyLit)
Source: SafetyLit - June 15, 2016 Category: Global & Universal Tags: Age: Adolescents Source Type: news

Resperidone (depot) for schizophrenia
Risperidone is the first new generation antipsychotic drug made available in a long-acting injection formulation. To examine the effects of depot risperidone for treatment of schizophrenia or related psychoses in comparison with placebo, no treatment or other antipsychotic medication. To critically appraise and summarise current evidence on the resource use, cost and cost-effectiveness of risperidone (depot) for schizophrenia. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 12, 2016 Category: Consumer Health News Source Type: news

Drug and behavioural therapy are both effective for tics in people with Tourette syndrome
There are effective drug and behavioural treatments for tics in children and young people with Tourette syndrome. Although most of the studies included in this review were small with risk of , the effects found were moderate to large and likely to be clinically meaningful. This NIHR funded and qualitative study found that habit reversal therapy, where people with Tourette's are taught to replace their tic with a less noticeable alternative, was effective. The drugs with the best balance of benefits and harms – risperidone, clonidine and aripiprazole – are those most commonly used in the UK. (Source: Current Awa...
Source: Current Awareness Service for Health (CASH) - April 7, 2016 Category: Consumer Health News Source Type: news